Hematologic Oncology Update

by Dr Neil Love
53

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.

More
Recent Episodes
  • Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
    Apr 22, 2025 – 40:11
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
    Apr 18, 2025 – 58:21
  • Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    Apr 15, 2025 – 43:18
  • Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
    Apr 12, 2025 – 50:12
  • Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
    Apr 4, 2025 – 58:13
  • Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses
    Mar 24, 2025 – 01:05:16
  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
    Mar 18, 2025 – 01:05:59
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
    Feb 25, 2025 – 02:33:01
  • Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
    Feb 19, 2025 – 46:45
  • Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
    Feb 11, 2025 – 46:45
  • Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series
    Jan 30, 2025 – 59:28
  • Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Jan 23, 2025 – 59:32
  • CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Jan 16, 2025 – 02:00:29
  • Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Jan 14, 2025 – 01:59:15
  • Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Jan 9, 2025 – 01:27:00
  • Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Jan 7, 2025 – 01:58:50
  • Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Dec 20, 2024 – 01:57:11
  • Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
    Dec 19, 2024 – 01:57:07
  • Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis
    Dec 17, 2024 – 51:43
  • Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes
    Dec 13, 2024 – 51:45
  • Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
    Dec 4, 2024 – 01:46:37
  • Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Multiple Myeloma
    Nov 26, 2024 – 52:45
  • Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
    Nov 22, 2024 – 58:36
  • Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care  — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Nov 20, 2024 – 56:11
  • What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
    Nov 8, 2024 – 56:15
  • Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
    Oct 30, 2024 – 57:58
  • Practical Perspectives: Current Management of Chronic Myeloid Leukemia
    Oct 24, 2024 – 01:49:21
  • Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
    Oct 17, 2024 – 46:33
  • Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
    Oct 10, 2024 – 58:58
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
    Aug 12, 2024 – 01:02:04
  • RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
    Jul 12, 2024 – 01:00:49
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
    Jul 2, 2024 – 01:00:07
  • Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
    May 29, 2024 – 01:16:46
  • Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    May 28, 2024 – 33:54
  • Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
    May 24, 2024 – 42:09
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
    May 14, 2024 – 01:02:07
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
    May 2, 2024 – 01:00:54
  • Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
    Apr 26, 2024 – 01:37:17
  • Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
    Apr 24, 2024 – 01:04:36
  • Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
    Apr 12, 2024 – 01:35:12
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
    Mar 27, 2024 – 01:00:13
  • Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
    Mar 8, 2024 – 01:00:13
  • Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
    Feb 27, 2024 – 58:02
  • Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
    Jan 17, 2024 – 01:00:25
  • Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
    Nov 10, 2023 – 01:01:30
  • Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
    Oct 20, 2023 – 01:01:44
  • What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
    Oct 19, 2023 – 01:01:33
  • Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
    Oct 18, 2023 – 01:19:48
  • Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
    Oct 12, 2023 – 46:28
  • What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
    Oct 9, 2023 – 47:30
Recent Reviews
  • Bongir
    A debt of gratitude that cannot be repaid
    That is how I feel about Dr Neil Love and his tireless work in continuing medical education for everyone in the medical field. These podcasts and discussions contained are informative, thought provoking and provide and excellent in depth but quick update in the rapidly ever-changing field of Hematology-Oncology.
  • ZomBucker
    Excellent content
    Always informative, always applies to those of us on the ground making difficult daily decisions on management in the community. Often with limited resources.
  • IanMack5000
    Excellent up to date reviews.
    I
Disclaimer: The podcast and artwork on this page are property of the podcast owner, and not endorsed by UP.audio.